Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Clinical characteristics and outcomes of patients with primary signet-ring cell carcinoma of the urinary bladder.

Wang J, Wang FW.

Urol Int. 2011;86(4):453-60. doi: 10.1159/000324263. Epub 2011 Apr 28.

PMID:
21525723
2.

Primary signet-ring cell carcinoma of the urinary bladder.

Akamatsu S, Takahashi A, Ito M, Ogura K.

Urology. 2010 Mar;75(3):615-8. doi: 10.1016/j.urology.2009.06.065. Epub 2009 Oct 12. Review.

PMID:
19819534
3.

Concurrent chemoradiotherapy for clinical stage T2 bladder cancer: report of a single institution.

Peyromaure M, Slama J, Beuzeboc P, Ponvert D, Debré B, Zerbib M.

Urology. 2004 Jan;63(1):73-7. Review.

PMID:
14751352
4.

Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.

George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, Serment G, Salem N.

Urology. 2004 Sep;64(3):488-93. Review.

PMID:
15351577
5.

[Transitional cell carcinoma of the urinary bladder accompanied by signet-ring cell carcinoma: a case report].

Ozeki Z, Kobayashi S, Machida T, Ishizaka K, Oka T.

Hinyokika Kiyo. 2003 Jul;49(7):411-3. Review. Japanese.

Supplemental Content

Support Center